This Government Contract opportunity from Department Of Health And Human Services was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Molecular Diagnostics Testing Services
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract entails providing clinical-grade molecular diagnostics testing services utilizing the QX200 ddPCR platform to support cancer diagnosis, prognosis, and identification of therapeutic targets. The scope of work includes assay execution, data analysis, quality control, and comprehensive reporting based on human patient samples. This subcontract is designated as a Total Small Business Set-Aside under SBA regulations, specifically aligned with NAICS code 621511, which pertains to medical laboratories. Awarded through the National Institutes of Health under the Department of Health and Human Services, the place of performance is in Bethesda, with a contract posted in mid-May 2026 and responses due by late May 2026. The focus is on delivering high-precision diagnostic testing to aid in clinical decision-making for cancer care, emphasizing rigorous quality standards and data integrity throughout the testing process.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
